Dendreon Files for Bankruptcy as Cancer Drug Disappoints

Dendreon Files for Bankruptcy as Cancer Drug Disappoints

Wednesday, November 12, 2014
Please note that in order to view the content for the Bankruptcy Headlines you must either sign in if you are already an ABI member, or otherwise you may Become an ABI Member
© American Bankruptcy Institute. All rights reserved. ABI is a (501)(c)(3) non-profit business (52-1295453)